ADVENT CAPITAL MANAGEMENT /DE/ - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 30 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
ADVENT CAPITAL MANAGEMENT /DE/ ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2019$22,019,000
-13.1%
24,758,000
-9.3%
0.43%
-23.8%
Q1 2019$25,344,000
+62.6%
27,289,000
+47.4%
0.56%
+48.3%
Q4 2018$15,585,000
-35.5%
18,512,000
-28.3%
0.38%
-24.3%
Q3 2018$24,147,000
+145.7%
25,827,000
+182.9%
0.50%
+140.6%
Q2 2018$9,826,000
-9.2%
9,129,000
-1.6%
0.21%
-2.8%
Q1 2018$10,824,000
+9.3%
9,279,000
+26.6%
0.21%
+12.1%
Q4 2017$9,903,000
-10.4%
7,328,000
+2.8%
0.19%
-9.1%
Q3 2017$11,056,000
-16.7%
7,131,000
-8.9%
0.21%
-17.7%
Q2 2017$13,277,000
-50.0%
7,826,000
-62.0%
0.25%
-48.8%
Q1 2017$26,533,000
+13.3%
20,585,000
-9.4%
0.50%
+15.1%
Q4 2016$23,415,000
+323.4%
22,721,000
+291.5%
0.43%
+438.8%
Q3 2016$5,530,000
-41.7%
5,803,000
-47.2%
0.08%
-45.2%
Q4 2015$9,492,000
-43.1%
11,000,000
+10.0%
0.15%
-42.7%
Q3 2015$16,669,00010,000,0000.26%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 69,346,000$107,321,0003.81%
PFM Health Sciences, LP 34,710,000$53,670,0001.06%
Partner Investment Management, L.P. 556,000$860,0000.82%
Myriad Asset Management Ltd. 5,000,000$7,731,0000.75%
SYMPHONY ASSET MANAGEMENT LLC 4,000,000$6,185,0000.69%
CAPSTONE INVESTMENT ADVISORS, LLC 9,074,000$14,030,0000.49%
CSS LLC/IL 5,251,000$8,112,0000.40%
SSI INVESTMENT MANAGEMENT LLC 2,813,000$4,333,0000.37%
ADVENT CAPITAL MANAGEMENT /DE/ 7,131,000$11,056,0000.21%
D. E. Shaw & Co., Inc. 27,750,000$42,835,0000.07%
View complete list of CLOVIS ONCOLOGY INC shareholders